β¨ Medicines Notices
NEW ZEALAND GAZETTE, No. 34 β 21 APRIL 2016
Product:
Infanrix-Hib vaccine
Component 1:
Active Ingredients:
Detoxified pertussis toxin 25mcg
Diphtheria toxoid, adsorbed 30IU
Pertactin 8mcg
Pertussis filamentous haemagglutinin 25mcg
Tetanus toxoid 40IU
Dosage Form:
Suspension for injection
Component 2:
Active Ingredient:
Haemophilus influenzae vaccine, tetanus toxoid conjugate 10mcg
Dosage Form:
Powder for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
GlaxoSmithKline Biologicals SA, Wavre, Belgium
GlaxoSmithKline Manufacturing SpA, Parma, Italy
GlaxoSmithKline Biologicals (Saint-Amand-Les-Eaux), Saint-Amand-Les-Eaux, France
Product:
Infanrix-IPV+Hib
Component 1:
Active Ingredients:
Detoxified pertussis toxin 25mcg
Diphtheria toxoid, adsorbed 30IU
Pertactin 8mcg
Pertussis filamentous haemagglutinin 25mcg
Polio virus type 1 40DAgU
Polio virus type 2 8DAgU
Polio virus type 3 32DAgU
Tetanus toxoid, adsorbed 40IU
Dosage Form:
Suspension for injection
Component 2:
Active Ingredient:
Haemophilus influenzae vaccine, tetanus toxoid conjugate 10mcg
Dosage Form:
Powder for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
GlaxoSmithKline Biologicals SA, Wavre, Belgium
GlaxoSmithKline Manufacturing SpA, Parma, Italy
GlaxoSmithKline Biologicals (Saint-Amand-Les-Eaux), Saint-Amand-Les-Eaux, France
Product:
Synflorix
Active Ingredients:
Pneumococcal Polysaccharide type 1 1mcg
Pneumococcal Polysaccharide type 14 1mcg
Pneumococcal Polysaccharide type 18C 3mcg
Pneumococcal Polysaccharide type 19F 3mcg
Pneumococcal Polysaccharide type 23F 1mcg
Pneumococcal Polysaccharide type 4 3mcg
Pneumococcal Polysaccharide type 5 1mcg
Pneumococcal Polysaccharide type 6B 1mcg
Pneumococcal Polysaccharide type 7F 1mcg
Pneumococcal Polysaccharide type 9V 1mcg
Dosage Form:
Suspension for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
GlaxoSmithKline Biologicals (Saint-Amand-Les-Eaux), Saint-Amand-Les-Eaux, France
Dated this 15th day of April 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go2199
Acting District Court Judge Appointed
51
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to Distribution of Infanrix-Hib Vaccine
π₯ Health & Social Welfare15 April 2016
Vaccine, Infanrix-Hib, Distribution, Medsafe, GlaxoSmithKline
- Chris James, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to Distribution of Infanrix-IPV+Hib Vaccine
π₯ Health & Social Welfare15 April 2016
Vaccine, Infanrix-IPV+Hib, Distribution, Medsafe, GlaxoSmithKline
- Chris James, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to Distribution of Synflorix Vaccine
π₯ Health & Social Welfare15 April 2016
Vaccine, Synflorix, Distribution, Medsafe, GlaxoSmithKline
- Chris James, Acting Group Manager, Medsafe, Ministry of Health
βοΈ Acting District Court Judge Appointed
βοΈ Justice & Law EnforcementJudge, Appointment, District Court
NZ Gazette 2016, No 34